Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA)
6.7300
-2.9800 (-30.69%)
NYSE · Last Trade: Feb 27th, 4:03 PM EST
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · February 27, 2026
Which stocks are moving on Friday?chartmill.com
Via Chartmill · February 27, 2026
What's going on in today's pre-market sessionchartmill.com
Via Chartmill · February 27, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · February 26, 2026

Via Benzinga · November 11, 2024
The ambitious dream of humanity establishing permanent settlements beyond Earth is taking a significant leap forward, not through advanced robotics or colossal spacecraft, but with the humble power of space-hardy organisms, particularly moss and various extremophiles. These resilient life forms are emerging as foundational components for creating sustainable extraterrestrial ecosystems, offering a biologically integrated pathway [...]
Via TokenRing AI · November 24, 2025
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results.
Via Benzinga · November 7, 2025
Via Benzinga · October 8, 2025
A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered elusive due to their dynamic and shapeless nature. This breakthrough, spearheaded by researchers at Harvard University and Northwestern University, leverages a novel machine learning method to precisely engineer IDPs with customizable [...]
Via TokenRing AI · October 6, 2025
Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.
Via Benzinga · August 21, 2025
Ginkgo Bioworks (DNA) meets Minervini Trend Template criteria with strong technicals, earnings growth, and momentum, making it a high-growth stock to watch.
Via Chartmill · August 1, 2025
Via Benzinga · June 30, 2025
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Via Benzinga · April 14, 2025
Via Benzinga · April 11, 2025

Via Benzinga · February 26, 2025

U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.
Via Benzinga · February 26, 2025

Via Benzinga · February 26, 2025

Via Benzinga · February 6, 2025

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on.
Via Benzinga · September 18, 2024

The company is forging ahead with next-generation drug development solutions.
Via The Motley Fool · September 17, 2024
